GreenLight Biosciences, Epivax Ink Collaboration Deal To Develop Personalized Cancer Vaccines

RTTNews | 911 days ago
Stocktwits
GreenLight Biosciences, Epivax Ink Collaboration Deal To Develop Personalized Cancer Vaccines

(RTTNews) - Biotechnology company GreenLight Biosciences Holdings, PBC (GRNA), and EpiVax Therapeutics Inc, announced Monday that they have signed an exclusive collaboration agreement to jointly develop and commercialize personalized mRNA-based vaccine candidates for cancers.

Under this collaboration, the companies will design and develop new personalized mRNA cancer vaccine candidates using GreenLight and EpiVax Therapeutics technology platforms.

EpiVax Therapeutics has developed a proprietary computational tool for precision immunotherapy, Ancer. GreenLight's mRNA design, formulation and manufacturing expertise is currently applied to research and develop mRNA vaccine candidates. Together, GreenLight and EpiVax Therapeutics will leverage their respective expertise and jointly develop and commercialize potential novel personalized mRNA-based vaccine candidates for a wide range of oncology indications.

Tags: GRNA
Stocktwits
read more
UK Stocks Turning In Mixed Performance In Cautious Trade

UK Stocks Turning In Mixed Performance In Cautious Trade

U.K. stocks are turning in a mixed performance Tuesday morning as investors are treading cautiously, keeping track of U.S. President Donald Trump's tariff plans and the potential risks to global economic growth.
RTTNews | 8h 7min ago
CAC 40 Slightly Lower In Lackluster Trade

CAC 40 Slightly Lower In Lackluster Trade

French stocks are slightly lower on Tuesday with investors making cautious moves while closely following the developments on the trade front.
RTTNews | 8h 53min ago
Australia Central Bank Unexpectedly Maintains Status Quo

Australia Central Bank Unexpectedly Maintains Status Quo

The Reserve Bank of Australia adopted a wait-and-see approach on Tuesday, defying expectations for a quarter-point rate cut but confirmed that an easing cycle is coming. The policy board, governed by Michele Bullock, decided to hold the cash rate target at 3.85 percent. A majority of six members voted to hold the rate, while three members sought a change from 3.85 percent.
RTTNews | 9h 4min ago
Tools
Economic Calendar
Market Hours
Interest Rates
Holidays Calendar
Forex Market
Forex Volatility
Forex Correlation
Forex News
forex analysis
COT Data
Liquidity
Forex Calculators
Forex Heat Map
Indicators Heatmap
Community
Community
Systems
Most Popular Systems
Strategies
Contests
Forex Charts
Forex Sentiment
Sentiment Indicator
Reviews
Brokers
Prop Trading Firms
VPS Services
Signal Providers
EA Programming Services
Affiliate Programs
PAMM Broker Services
Rebate Program Services
Trading Platforms
Expert Advisors
Crypto Exchanges
Trading Courses
Brokers
Forex Spreads
Forex Broker Quotes
Forex Broker Swaps
Forex Broker Volume
Forex Broker Promotions Press Release
Platform
Widgets
Features
API
RSS
Stock Portfolio
Affiliate Software
Advanced Charts
Support
FAQ
Help
Contact Us
Report a Bug!
About
Blog
© 2025 Myfxbook Ltd. All Rights Reserved.
HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.